Dr. Reddy's Laboratories Limited (BOM:500124)

Dr. Reddy's Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	325,535	279,164	245,879	214,391	189,722
Revenue Growth (YoY)	16.61%	13.54%	14.69%	13.00%	8.66%
Cost of Revenue	135,107	115,557	106,536	100,551	86,645
Gross Profit	190,428	163,607	139,343	113,840	103,077
Selling, General & Admin	92,853	77,201	68,026	62,081	54,650
Research & Development	27,380	22,873	19,381	17,482	16,541
Other Operating Expenses	-4,358	-1,775	-1,480	-1,642	-1,024
Operating Expenses	115,875	98,299	85,927	77,921	70,167
Operating Income	74,553	65,308	53,416	35,919	32,910
Interest Expense	-2,829	-1,711	-1,428	-958	-970
Interest & Investment Income	7,553	2,278	1,180	965	826
Earnings From Equity Investments	217	147	370	703	480
Currency Exchange Gain (Loss)	-	278	2,225	1,835	1,240
Other Non Operating Income (Expenses)	-	46	-152	277	557
EBT Excluding Unusual Items	79,494	66,346	55,611	38,741	35,043
Merger & Restructuring Charges	-1,017	-	-	-	-
Gain (Loss) on Sale of Investments	-	3,103	1,028	-	-
Gain (Loss) on Sale of Assets	-	900	-1,211	1,119	-42
Asset Writedown	-1,693	-3	-699	-7,562	-8,588
Legal Settlements	-	1,524	5,638	-	-
Pretax Income	76,784	71,870	60,367	32,298	26,413
Income Tax Expense	19,539	16,186	15,300	8,730	9,175
Earnings From Continuing Operations	57,245	55,684	45,067	23,568	17,238
Minority Interest in Earnings	-701	-	-	-	-
Net Income	56,544	55,684	45,067	23,568	17,238
Net Income to Common	56,544	55,684	45,067	23,568	17,238
Net Income Growth	1.54%	23.56%	91.22%	36.72%	-11.59%
Shares Outstanding (Basic)	833	832	830	829	829
Shares Outstanding (Diluted)	834	834	832	832	832
Shares Change (YoY)	0.08%	0.19%	0.03%	0.01%	0.14%
EPS (Basic)	67.88	66.93	54.29	28.42	20.79
EPS (Diluted)	67.78	66.80	54.17	28.34	20.73
EPS Growth	1.46%	23.32%	91.16%	36.70%	-11.71%
Free Cash Flow	18,924	29,030	47,552	13,448	25,962
Free Cash Flow Per Share	22.68	34.83	57.16	16.17	31.22
Dividend Per Share	8.000	8.000	8.000	6.000	5.000
Dividend Growth	-	-	33.33%	20.00%	-
Gross Margin	58.50%	58.61%	56.67%	53.10%	54.33%
Operating Margin	22.90%	23.39%	21.73%	16.75%	17.35%
Profit Margin	17.37%	19.95%	18.33%	10.99%	9.09%
Free Cash Flow Margin	5.81%	10.40%	19.34%	6.27%	13.68%
EBITDA	91,611	79,006	65,173	47,743	45,706
EBITDA Margin	28.14%	28.30%	26.51%	22.27%	24.09%
D&A For EBITDA	17,058	13,698	11,757	11,824	12,796
EBIT	74,553	65,308	53,416	35,919	32,910
EBIT Margin	22.90%	23.39%	21.73%	16.75%	17.35%
Effective Tax Rate	25.45%	22.52%	25.35%	27.03%	34.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.